Paul Kaufman Hopeful, Inspired for Future of Glaucoma Research


The esteemed ophthalmologist spoke of novel therapies, importance of collaboration.

For the third installment of an insightful interview with Paul Kaufman, MD, the tenured expert dove in on his hopes for the future of glaucoma research and treatment.

Kaufman also spoke of the importance of having a physical meeting like ARVO every year in maintaining advances and facilitating real collaboration. And he would know the significance: on top of being the Chair-Emeritus of the Department of Ophthalmology & Visual Sciences at the University of Wisconsin School of Medicine and Public Health, he formerly was President and Executive Vice President of the Association for Research in Vision and Ophthalmology (ARVO).

At ARVO 2017, he delivered a keynote lecture on glaucoma and presbyopia and was awarded Friedenwald Award for his work.

Recent Videos
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
A panel of 3 experts on dry eye
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Viability of Elamipretide for Geographic Atrophy in Dry AMD | Image Credit: HCPLive
Advancing Elamipretide into Phase 3 ReNEW and ReGAIN Trials | Image Credit: HCPLive
Elamipretide in ReCLAIM-2 Trial | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.